FierceBiotech 2025-12-01 Akebia to pay $12M to Q32 Bio for centerpiece of rare kidney disease pipeline
10x Genomics Blog 2025-12-01 Comparative Study of Two Innovative Single-Cell RNA Platforms - Bioengineer.org
Agilent 2025-12-01 Rothschild & Co Redburn Adjusts Price Target on Agilent Technologies to $180 From $165, Maintains Buy Rating - MarketScreener
Agilent 2025-12-01 Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight - WebWire
Thermo Fisher 2025-12-01 Thermo Fisher Scientific launches CorEvitas Clinical Registry for rare autoimmune disorder - scientistlive.com
Agilent 2025-12-01 Agilent Announces 21 Cfr Part 11 Compliance Software For Xcelligence RTCA eSight - TradingView
Agilent 2025-12-01 Mackenzie Financial Corp Cuts Position in Agilent Technologies, Inc. $A - MarketBeat